Harpoon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch HARP and buy or sell other stocks, options, and ETFs commission-free!

About HARP

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. 

CEO
Julia Marie Eastland, MBA
CEOJulia Marie Eastland, MBA
Employees
50
Employees50
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2015
Founded2015
Employees
50
Employees50

HARP Key Statistics

Market cap
94.54M
Market cap94.54M
Price-Earnings ratio
-2.64
Price-Earnings ratio-2.64
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$23.21
52 Week high$23.21
52 Week low
$3.11
52 Week low$3.11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.